Hepatitis B vaccine: only 25% of adults aged above 40 developed antibodies. 75% remained unprotected.

The propaganda machine, idiotic bureaucrats and "scholars" say that an impossible injectable snake oil is the ultimate solution for COVID-19.

Last update and review: May 23, 2020.

Propaganda and idiotic bureaucrats and “scholars” want government to make COVID-19 vaccination compulsory.

The propaganda machine, idiotic bureaucrats and “scholars” are repeating that a vaccine is the ultimate solution to COVID-19. Here is, for example, what Merrill Matthews, “Resident Scholar” from the “Institute for Policy Innovation” in the University of Texas, Dallas, in the US, writes for a propaganda outlet “The Hill”:

When a COVID-19 vaccine becomes available, I will be one of the first in line. But the fact is U.S. adults tend to have low vaccination rates. If the government determines that vaccinations are essential to stemming the spread of the disease, would it – could it – mandate vaccination compliance? Apparently, it can — and it might.

Date of the online publication: May 20, 2020.

We covered the problems related to vaccines in general and to vaccines against coronaviruses many times. In short, in the most vulnerable group, older adults, a majority does not develop antibodies after vaccination. And a majority of vaccines, failed and currently approved, may cause immune pathology.

Deconstruction of the study by Afsharian et al., 2019 (1).

Hepatitis B vaccines provide an example of the approved vaccines that do not work well. In a 2019 study by Afsharian et al. (1), the researchers administered a hepatitis B vaccine manufactured by a Korean company Hepavax to adults aged 40 and above. The study was conducted in Iran, where hepatitis B is a considerable concern. The researches found that in one of the study arms, only a quarter of the subjects developed antibodies to hepatitis B. The rest of the subjects remained unprotected against hepatitis B. In the other arm of the study, only 36.5% developed antibodies to hepatitis B, but the difference between the groups was not statistically significant.

The study subjects.

Afsharian et al. 2019 (1):

In a clinical trial on 140 subjects aged ≥40 years with a body mass index (BMI) <30 kg/m2, and without any co-morbid disease. Those who had negative hepatitis B core antibody (102 persons) were randomly allocated to two groups.

The median age of participants was 47 (range: 40–73) years.

Hepatitis B vaccine plus 200 mg zinc sulfate daily for 30 days.

Afsharian et al. 2019 (1):

The trial group received hepatitis B vaccine plus 200 mg zinc sulfate daily for 30 days and the control group received vaccine plus placebo.

The proportions of people who were protected after vaccination was 26.0% with zinc and 36.5% without zinc, however, the difference was not statistically significant.

Afsharian et al. 2019 (1):

The mean antibody production in the intervention and control groups was 116.93 and 157.37 mIU/mL, respectively (p=0.22). No statistical differences were observed between the two groups in terms of proportion of people who were protected after vaccination (26.0% and 36.5% in people with and without zinc, respectively).

The impact of 30 days of zinc supplementation after vaccination.

The authors (1) concluded that zinc sulfate supplementation has no effect on the level of immunity among adults aged fourty and above following vaccination with a hepatitis B vaccine.

Hepatitis B vaccination does not reduce the infection rate in Iran.

Afsharian et al. 2019 (1):

The prevalence of infection in Iran is estimated to be 2.14% in men and 2.55% in women.

It seems that in endemic regions (of Iran) hepatitis B vaccination have a significant effect on reducing the chronic infection and carrier state, but may not reduce the infection rate

COVID-19 vs hepatitis B.

COVID-19 vs hepatitis B: 70 million infected vs 2 billion infected worldwide, respectively.

Afsharian et al. 2019 (1):

Hepatitis B (HBV) is a major public health problem with two billion
people infected worldwide.

HBV is the most important cause of viral hepatitis in the world that can cause cirrhosis and liver cancer. More than 350 million people are chronic carriers of HBV.

The question: If it takes only six months for Pharma companies to create a safe and effective vaccine against COVID-19, why haven’t Pharma companies created a more effective and safe vaccine that could solve the hepatitis B pandemic?

Global viral hepatitis deaths in 2013 were estimated at 1.45 millions.

Stanaway et al., 2013 (2):

Between 1990 and 2013, global viral hepatitis deaths increased from 0·89 million (95% uncertainty interval [UI] 0·86-0·94) to 1·45 million (1·38-1·54).

As of May 20, 2020, COVID-19 deaths worldwide are estimated at 326 thousand. Hepatitis B kills more than 4 times more each year (the 2013 estimate is 1.46 millions).
As of May 20, 2020, COVID-19 deaths worldwide are estimated at 326 thousand. Hepatitis B kills more than 4 times more each year (the 2013 estimate is 1.46 millions).

Rhetorical questions:

Why vaccination has not solved the hepatitis B pandemic?

Why there is no ban on international travel and no testing at the border to protect countries from hepatitis B?

Conclusions.

If bureaucrats and propagandists receive an order to push an ineffective and unsafe vaccine against COVID-19, they will do so.

The most likely scenario is that one or several ineffective and unsafe vaccines against COVID-19 will be rushed to market in the next months. These vaccines will be likely to cause the characteristic immune pathology and some may cause antibody-dependent enhancement of SARS-CoV-2 infection (ADE). Bureaucracies and propaganda in most of the countries were hijacked long time ago and are executing orders coming from unknown entities. So, if bureaucrats and propagandists receive an order to push an ineffective and unsafe vaccine against COVID-19, they will do so.

Who holds the remote control that animates and directs the idiotic and criminal bureaucrats all over the world?
Who holds the remote control that animates and directs the idiotic and criminal bureaucrats all over the world?

Illiterate, vulnerable, psychotic fractions of the population, as well as some lackey intelligentsia, may line up for vaccination voluntarily.

Illiterate, vulnerable, psychotic fractions of the population, as well as some lackey intelligentsia, may line up for vaccination volontarily. After a period of time, there may be a scandal and the vaccination will be stopped. That is one scenario. Another scenario is that ineffective and unsafe COVID-19 vaccines will become a chronic problem like a number of other ineffective and unsafe vaccines imposed on children and adults. Finally, if criminal idiotic bureaucrats declare vaccination with ineffective and unsafe vaccines compulsory, it will be the worst scenario.

The research and the use of vaccines must be supervised by the smartest representatives of local communities worldwide.

Vaccines can be a useful tool to combat disease. However, the research and the use of vaccines must be supervised by the smartest representatives of different local communities worldwide. This is not going to happen soon. Therefore, in the foreseeable future, anything related to vaccination should be approached with extreme caution.

You should avoid COVID-19 vaccination and resist any compulsory vaccination by all means.

Regarding COVID-19, the best strategy is to avoid getting infected.

Regarding COVID-19, the best strategy is to avoid getting infected. It is not very difficult. Use different ways to boost your innate immune system as an extra measure. If infected, start the treatment early and make sure your treatment protocol is the most optimal given the current knowledge. It is also a good time to find a good medical practitioner who can support you.

If you need help with the above, do not hesitate to get in contact with us.

Selected references:

1. Afsharian M, Vaziri S, Janbakhsh AR, Sayad B, Mansouri F, Nourbakhsh J, et al. The effect of zinc sulfate on immunologic response to recombinant hepatitis B vaccine in elderly. Hepat Mon. 2011;11(1):32-35.

2. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016;388(10049):1081‐1088. doi:10.1016/S0140-6736(16)30579-7

1 Comment

Leave a Reply

Your email address will not be published. Required fields are marked *